Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target

Adipokines are essential mediators produced by adipose tissue and exert multiple biological functions. In particular, adiponectin, leptin, resistin, IL-6, MCP-1 and PAI-1 play specific roles in the crosstalk between adipose tissue and other organs involved in metabolic, immune and vascular health. D...

Full description

Bibliographic Details
Main Authors: Teva Turpin, Katy Thouvenot, Marie-Paule Gonthier
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/13/12/1692
_version_ 1827575503708487680
author Teva Turpin
Katy Thouvenot
Marie-Paule Gonthier
author_facet Teva Turpin
Katy Thouvenot
Marie-Paule Gonthier
author_sort Teva Turpin
collection DOAJ
description Adipokines are essential mediators produced by adipose tissue and exert multiple biological functions. In particular, adiponectin, leptin, resistin, IL-6, MCP-1 and PAI-1 play specific roles in the crosstalk between adipose tissue and other organs involved in metabolic, immune and vascular health. During obesity, adipokine imbalance occurs and leads to a low-grade pro-inflammatory status, promoting insulin resistance-related diabetes and its vascular complications. A causal link between obesity and gut microbiota dysbiosis has been demonstrated. The deregulation of gut bacteria communities characterizing this dysbiosis influences the synthesis of bacterial substances including lipopolysaccharides and specific metabolites, generated via the degradation of dietary components, such as short-chain fatty acids, trimethylamine metabolized into trimethylamine-oxide in the liver and indole derivatives. Emerging evidence suggests that these bacterial metabolites modulate signaling pathways involved in adipokine production and action. This review summarizes the current knowledge about the molecular links between gut bacteria-derived metabolites and adipokine imbalance in obesity, and emphasizes their roles in key pathological mechanisms related to oxidative stress, inflammation, insulin resistance and vascular disorder. Given this interaction between adipokines and bacterial metabolites, the review highlights their relevance (i) as complementary clinical biomarkers to better explore the metabolic, inflammatory and vascular complications during obesity and gut microbiota dysbiosis, and (ii) as targets for new antioxidant, anti-inflammatory and prebiotic triple action strategies.
first_indexed 2024-03-08T20:58:02Z
format Article
id doaj.art-bf221290fbc6437491f164aa24563446
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-08T20:58:02Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-bf221290fbc6437491f164aa245634462023-12-22T13:55:47ZengMDPI AGBiomolecules2218-273X2023-11-011312169210.3390/biom13121692Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to TargetTeva Turpin0Katy Thouvenot1Marie-Paule Gonthier2Université de La Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), 97410 Saint-Pierre, La Réunion, FranceUniversité de La Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), 97410 Saint-Pierre, La Réunion, FranceUniversité de La Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), 97410 Saint-Pierre, La Réunion, FranceAdipokines are essential mediators produced by adipose tissue and exert multiple biological functions. In particular, adiponectin, leptin, resistin, IL-6, MCP-1 and PAI-1 play specific roles in the crosstalk between adipose tissue and other organs involved in metabolic, immune and vascular health. During obesity, adipokine imbalance occurs and leads to a low-grade pro-inflammatory status, promoting insulin resistance-related diabetes and its vascular complications. A causal link between obesity and gut microbiota dysbiosis has been demonstrated. The deregulation of gut bacteria communities characterizing this dysbiosis influences the synthesis of bacterial substances including lipopolysaccharides and specific metabolites, generated via the degradation of dietary components, such as short-chain fatty acids, trimethylamine metabolized into trimethylamine-oxide in the liver and indole derivatives. Emerging evidence suggests that these bacterial metabolites modulate signaling pathways involved in adipokine production and action. This review summarizes the current knowledge about the molecular links between gut bacteria-derived metabolites and adipokine imbalance in obesity, and emphasizes their roles in key pathological mechanisms related to oxidative stress, inflammation, insulin resistance and vascular disorder. Given this interaction between adipokines and bacterial metabolites, the review highlights their relevance (i) as complementary clinical biomarkers to better explore the metabolic, inflammatory and vascular complications during obesity and gut microbiota dysbiosis, and (ii) as targets for new antioxidant, anti-inflammatory and prebiotic triple action strategies.https://www.mdpi.com/2218-273X/13/12/1692adipokinesbacterial metabolitesgut microbiota dysbiosisinsulin resistanceobesityvascular disorder
spellingShingle Teva Turpin
Katy Thouvenot
Marie-Paule Gonthier
Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
Biomolecules
adipokines
bacterial metabolites
gut microbiota dysbiosis
insulin resistance
obesity
vascular disorder
title Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
title_full Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
title_fullStr Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
title_full_unstemmed Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
title_short Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
title_sort adipokines and bacterial metabolites a pivotal molecular bridge linking obesity and gut microbiota dysbiosis to target
topic adipokines
bacterial metabolites
gut microbiota dysbiosis
insulin resistance
obesity
vascular disorder
url https://www.mdpi.com/2218-273X/13/12/1692
work_keys_str_mv AT tevaturpin adipokinesandbacterialmetabolitesapivotalmolecularbridgelinkingobesityandgutmicrobiotadysbiosistotarget
AT katythouvenot adipokinesandbacterialmetabolitesapivotalmolecularbridgelinkingobesityandgutmicrobiotadysbiosistotarget
AT mariepaulegonthier adipokinesandbacterialmetabolitesapivotalmolecularbridgelinkingobesityandgutmicrobiotadysbiosistotarget